BFM
GCTK icon

Boston Financial Management’s GlucoTrack GCTK Stock Holding History

Boston Financial Management’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$6.9K – 333
2023
Q4 		$6.9K Sell
4
-5
-56% -$6.63K ﹤0.01% 315
2023
Q3 		$13.8K Buy
+9
New +$16.2K ﹤0.01% 300
2023
Q2 		– Sell
-4
Closed -$8.97K – 312
2023
Q1 		$8.97K Hold
4
– – ﹤0.01% 308
2022
Q4 		$37.2K Hold
4
– – ﹤0.01% 318
2022
Q3 		$51K Hold
4
– – ﹤0.01% 299
2022
Q2 		$68K Hold
4
– – ﹤0.01% 281
2022
Q1 		$96K Hold
4
– – ﹤0.01% 283
2021
Q4 		$110K Buy
+4
New +$92.9K ﹤0.01% 260

Other funds holding GCTK

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VCM
Virtue Capital Management Brentwood, Tennessee $657M AUM 24.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boston Financial Management's GCTK Position: Q1 2024 in Review

Boston Financial Management sold out of GlucoTrack (GCTK) in Q1 2024, closing a stake of 4 shares — an estimated $6.9K sold.

Boston Financial Management first reported a position in GCTK in Q4 2021 and held it in 8 quarters. The position peaked at $110K in Q4 2021. 7 funds tracked by Wall St. Rank hold GCTK as of Q1 2024.

  • Boston Financial Management reported no remaining GlucoTrack position as of Q1 2024 after selling out during the quarter.
  • Boston Financial Management sold 4 GlucoTrack shares in Q1 2024, an estimated $6.9K.
  • Boston Financial Management first reported a position in GlucoTrack in Q4 2021 and held it in 8 quarters.
  • Boston Financial Management's GlucoTrack position peaked at $110K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2024.

Based on Boston Financial Management's 13F filing for Q1 2024, filed 10 May 2024.